Results 301 to 310 of about 184,433 (313)

Anti-PD-1 therapies—a new first-line option in advanced melanoma

Nature Reviews Clinical Oncology, 2015
Ryan J Sullivan, Keith T Flaherty, Sullivan Ryan J   +2 more
exaly  

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly  

The Changing Kinetics of Advanced Melanoma

JAMA Dermatology, 2019
openaire   +2 more sources

The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs

Ca-A Cancer Journal for Clinicians, 2010
D S Rigel, Robert Friedman
exaly  

Reality check for nivolumab in advanced-stage melanoma

Nature Reviews Clinical Oncology, 2017
Diana Romero, Romero Diana
exaly  

Malignant melanoma: prevention, early detection, and treatment in the 21st century

Ca-A Cancer Journal for Clinicians, 2000
D S Rigel, Darrell S Rigel, John A Carucci   +2 more
exaly  

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Lancet, The, 2014
Caroline Robert, Antoni Ribas, Omid Hamid   +2 more
exaly  

Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

Value in Health, 2017
Luis Silva MIGUEL
exaly  

Systematic review of psychosocial outcomes for patients with advanced melanoma

Psycho-Oncology, 2017
Jeff Dunn, Maggie Watson, Joanne F Aitken   +2 more
exaly  

Is Tremelimumab Beneficial in Advanced Melanoma?

Journal of Clinical Oncology, 2013
Kenneth S, Wilson, Rami, Kotb
openaire   +2 more sources